Experimental design-based optimization of lipid nanocarrier as delivery system against Mycobacterium species: in vitro and in vivo evaluation

References

• Global Tuberculosis Report. World Health Organization (WHO), 2014; Available from: www.who.int/tb [last accessed 25 Nov 2014].
   Google Scholar
• Choudhuri BS, Sen S, Chakrabarti P. Isoniazid accumulation in Mycobacterium smegmatis is modulated by proton motive force-driven and ATP-dependent extrusion systems. Biochem Biophys Res Commun 1999;256:682–684.
   PubMed Web of Science ®Google Scholar
• De Rossi E, Ainsa JA, Riccardi G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 2006;30:36–52.
   PubMed Web of Science ®Google Scholar
• Lin Y, Shen Q, Katsumi H, et al. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. Biol Pharm Bull 2007;30:1301–1307.
   PubMed Web of Science ®Google Scholar
• Hussain A, Singh SK. Evidences for anti-mycobacterium activities of lipids and surfactants. World J Microbiol Biotechnol 2016;32:7. doi: 10.1007/s11274-015-1965-4.
   PubMed Web of Science ®Google Scholar
• Singh N, Verma SM, Singh SK, Verma PRP. Evidence for bactericidal activities of lipidic nanoemulsions against Pseudomonas aeruginosa. Antonie Van Leeuwenhoek 2015;107:1555–1568.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Ramadan W, Rambhu D, Shakeel F. Potential of nanoemulsions for intravenous delivery of rifampicin. Die Pharm 2008;63:806–811.
   PubMed Web of Science ®Google Scholar
• Borges VR, Simon A, Sena AR, et al. Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation. Int J Nanomed 2013;8:535–544.
   PubMed Web of Science ®Google Scholar
• Cottle W. Chaulmoogra oil in leprosy. Br Med J 1879;1:968–969.
   PubMedGoogle Scholar
• Walker EL, Sweeney MA. The chemotherapeutics of the chaulmoogric acid series and other fatty acids in leprosy and tuberculosis. J Infect Dis 1920;26:238–264.
   Google Scholar
• Falkinham JO III, Macri RV, Maisuria BB, et al. Antibacterial activities of dendritic amphiphiles against non-tuberculous Mycobacteria. Tuberculosis 2012;92:173–181.
   PubMed Web of Science ®Google Scholar
• Patil PR, Biradar SV, Paradkar AR. Extended release felodipine self-nanoemulsifying system. AAPS PharmSciTech 2009;10:515–523.
   PubMed Web of Science ®Google Scholar
• Verma S, Singh SK, Prasad Verma PRP, Ahsan MN. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box–Behnken design. Drug Dev Ind Pharm 2014;40:1358–1370.
   PubMed Web of Science ®Google Scholar
• Derringer G, Suich R. Simultaneous optimization of several response variables. J Qual Tech 1980;12:214–219.
   Web of Science ®Google Scholar
• Singh SK, Verma PRP, Razdan B. Development and characterization of a lovastatin loaded self-microemulsifying drug delivery system. Pharm Dev Technol 2010;15:469–483.
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Nazish I, Ahmed FJ. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 2013;40:527–541.
   PubMed Web of Science ®Google Scholar
• Singh N, Verma SM, Singh SK, et al. Antibacterial activity of cationised and non-cationised placebo lipidic nanoemulsion using transmission electron microscopy. J Exp Nanosci 2013;10:299–309.
   Web of Science ®Google Scholar
• Hanh ND, Mitrevej A, Sathirakul K, et al. Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm 2015;41:1–11. doi: 10.3109/03639045.2013.858732.
   Web of Science ®Google Scholar
• Beg S, Jena SS, Patra CN, et al. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloid Surf B: Biointerfaces 2013;101:414–423.
   PubMed Web of Science ®Google Scholar
• Bleck CK, Merz A, Gutierrez MG, et al. Comparison of different methods for thin section EM analysis of Mycobacterium smegmatis. J Microsc 2010;237:23–38.
   PubMed Web of Science ®Google Scholar
• Dahl JL. Scanning electron microscopy analysis of aged Mycobacterium tuberculosis cells. Can J Microbiol 2005;51:277–281.
   PubMed Web of Science ®Google Scholar
• Deupree SM, Schoenfisch MH. Morphological analysis of the antimicrobial action of nitric oxide on Gram-negative pathogens using atomic force microscopy. Acta Biomater 2009;5:1405–1415.
   PubMed Web of Science ®Google Scholar
• Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21–43.
   PubMed Web of Science ®Google Scholar
• Gupta R, Bandana Thakur B, Singh P, et al. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J Med Res 2010;131:809–813.
   PubMed Web of Science ®Google Scholar
• Verma S, Singh SK, Verma PRP. Fabrication of lipidic nanocarriers of loratadine for facilitated intestinal permeation using multivariate design approach. Drug Dev Ind Pharm 2016;42:288–306.
   PubMed Web of Science ®Google Scholar
• Saleem TSM, Christina AJM, Chidambaranathan N, et al. Hepatoprotective activity of Annona squamosa Linn. on experimental animal model. Int J Appl Res Nat Prod 2008;1:1–7.
   Google Scholar
• Yue J, Peng RX, Yang J, et al. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol Sin 2004;25:699–704.
   PubMed Web of Science ®Google Scholar
• Karata A, Bekmezci E. Evaluation and enhancement of physical stability of semisolid dispersion containing piroxicam into hard gelatin capsule. Acta Poloniae Pharm Drug Res 2013;70:883–897.
   PubMed Web of Science ®Google Scholar
• Matsaridou I, Barmpalexis P, Salis A, Nikolakakis I. The influence of surfactant HLB and oil/surfactant ratio on the formation and properties of self-emulsifying pellets and microemulsion reconstitution. AAPS PharmSciTech 2012;13:1319–1330.
   PubMed Web of Science ®Google Scholar
• Hong T, Butler WR, Hollis F, et al. Characterization of a novel rapidly growing Mycobacterium species associated with sepsis. J Clin Microbiol 2003;41:5650–5653.
   PubMed Web of Science ®Google Scholar
• Best CA, Best TJ. Mycobacterium smegmatis infection of the hand. Hand (New York) 2009;4:165–166.
   PubMedGoogle Scholar
• Rahman MA, Hussain A, Hussain MS, et al. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 2013;39:1–19.
   PubMed Web of Science ®Google Scholar
• Arnold YE, Imanidis G, Kuentz M. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life. Drug Dev Ind Pharm 2012;38:1262–1269.
   PubMed Web of Science ®Google Scholar
• Shen Y, Lu Y, Jv M, et al. Enhancing effect of labrasol on the intestinal absorption of ganciclovir in rats. Drug Dev Ind Pharm 2011;37:1415–1421.
   PubMed Web of Science ®Google Scholar
• Baker JR Jr, Wright DC, Hayes MM, et al. Method for inactivating bacteria including bacterial spores. U.S. Patent 6015832; 2000
   Google Scholar
• Hamouda T, Baker JR Jr. Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli. J Appl Microbiol 2000;89:397–403.
   PubMed Web of Science ®Google Scholar
• Denyer SP, Stewart GSAB. Mechanism of action of disinfectants. Int Biodeterior Biodegradation 1998;41:261–268.
   Web of Science ®Google Scholar
• Yang S, Zhang F, Kang J, et al. Mycobacterium tuberculosis Rv1096 protein: gene cloning, protein expression and peptidoglycan deacetylase activity. BMC Microbiol 2014;14:174.
   PubMed Web of Science ®Google Scholar
• Yamada H, Mitarai S, Chikamatsu K, et al. Novel freeze-substitution electron microscopy provides new aspects of virulent Mycobacterium tuberculosis with visualization of the outer membrane and satisfying biosafety requirements. J Microbiol Methods 2010;80:14–18.
   PubMed Web of Science ®Google Scholar
• Jiang T, He L, Zhan Y. The effect of MSMEG_6402 gene disruption on the cell wall structure of Mycobacterium smegmatis. Microbial Pathogenesis 2011;51:156–160.
   PubMed Web of Science ®Google Scholar
• Mukherjee K, Tribedi P, Mukhopadhyay B, Sil AK. Antibacterial activity of long-chain fatty alcohols against mycobacteria. FEMS Microbiol Lett 2013;338:177–183.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release 2008;129:1–10.
   PubMed Web of Science ®Google Scholar
• Sha X, Yan G, Wu Y, et al. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci 2005;24:477–486.
   PubMed Web of Science ®Google Scholar
• Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 2008;60:673–691.
   PubMed Web of Science ®Google Scholar
• Jain SA, Makhija DT, Goel PN, et al. 2016. Docetaxel in cationic lipid nanocapsules for enhanced in vivo activity. Pharm Dev Technol 2016;21:76–85.
   PubMed Web of Science ®Google Scholar
• Tomita M, Hayashi M, Awazu S. Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells. J Pharmacol Exp Ther 1995;272:739–743.
   PubMed Web of Science ®Google Scholar
• Ilem-Ozdemir D, Gundogdu E, Ekinci M, et al. Comparative permeability studies with radioactive and nonradioactive risedronate sodium from self-microemulsifying drug delivery system and solution. Drug Dev Ind Pharm 2014;41:1493–1498.
   Web of Science ®Google Scholar
• Eedara BB, Veerareddy PR, Jukanti R, Bandari S. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. Drug Dev Ind Pharm 2014;40:1030–1043.
   PubMed Web of Science ®Google Scholar
• Garner P, Holmes A, Ziganahina L. Tuberculosis. Clin Evid 2004;11:1081–1093.
   PubMedGoogle Scholar
• Ramaiah SK, Apte U, Mehendale HIM. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab Dispos 2001;29:1088–1095.
   PubMed Web of Science ®Google Scholar
• Wu J, Leev S, Yeh P. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers. Gastroenterology 1990;98:502–504.
   PubMed Web of Science ®Google Scholar
• Yasuda K, Sato A, Chida K. Pulmonary tuberculosis with chemotherapy related liver dysfunction. Kekkadu 1990;65:407–413.
   PubMedGoogle Scholar
• Han Y, Li Y, Zhang P, et al. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Pharm Dev Technol 2016;21:277–281.
   PubMed Web of Science ®Google Scholar